![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Villanueva-Peñacarrillo María Puente Jesús Redondo Araceli Clemente Felipe Valverde Isabel
Publisher: Humana Press, Inc
ISSN: 0969-711X
Source: Endocrine Journal, Vol.15, Iss.2, 2001-07, pp. : 241-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Tardy-Cantalupi I. Montessuit C. Papageorgiou I. Remondino-Müller A. Assimacopoulos-Jeannet F. Morel D.R. Lerch R.
Journal of Molecular and Cellular Cardiology, Vol. 31, Iss. 5, 1999-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Huang C. Kim Y. Caramori M. Fish A. Rich S. Miller M. Russell G. Mauer M.
Diabetologia, Vol. 47, Iss. 10, 2004-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
GLP-1 receptor agonists in the treatment of Type 2 diabetes
By Ahrén Bo
Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adapting the GLP-1-Signaling System to the Treatment of Type 2 Diabetes
Current Diabetes Reviews, Vol. 3, Iss. 1, 2007-01 ,pp. :